Analyst Rating Changes — Upgrades, Downgrades & Price Targets

43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Price-Target Changes

WhenStockChange FirmAnalyst RatingPrice Target
Aug 27
13:44 UTC
NVDA
NVIDIA
◎ Target Truist Financial William Stein ★★☆☆☆ #2647 Buy $307.00→ $346.00+12.7%
Aug 27
13:44 UTC
NTNX
Nutanix
◎ Target Morgan Stanley Meta Marshall ★★★☆☆ #1570 Equal Weight $55.00→ $63.00+14.5%
Aug 27
13:44 UTC
META
Meta Platforms
◎ Target Truist Financial Youssef Squali ★★★☆☆ #1118 Buy $770.00→ $763.00-0.9%
Aug 27
13:44 UTC
META
Meta Platforms
◎ Target Rosenblatt Securities Barton Crockett ★★★★☆ #650 Buy $883.00→ $886.00+0.3%
Aug 27
13:44 UTC
KSS
Kohl's
◎ Target Telsey Advisory Group Dana Telsey ★★★☆☆ #991 Market Perform $17.00→ $18.00+5.9%
Aug 27
13:44 UTC
IRM
Iron Mountain
◎ Target Truist Financial Tobey Sommer ★★★★★ #212 Buy $140.00→ $155.00+10.7%
Aug 27
13:44 UTC
FOUR
Shift4 Payments
◎ Target Truist Financial Matthew Coad ★★★★☆ #358 Hold $50.00→ $49.00-2.0%
Aug 27
13:44 UTC
DY
Dycom Industries
◎ Target KeyCorp Sangita Jain ★☆☆☆☆ #2921 Overweight $610.00→ $423.00-30.7%
Aug 27
13:44 UTC
DRI
Darden Restaurants
◎ Target KeyCorp Christopher Carril ★★★☆☆ #1758 Overweight $228.00→ $237.00+3.9%
Aug 27
13:44 UTC
DLO
DLocal
◎ Target Truist Financial Matthew Coad ★★★★☆ #358 Buy $17.00→ $18.00+5.9%
Aug 27
13:44 UTC
DEA
Easterly Government Properties
◎ Target Truist Financial Michael Lewis ★★★★☆ #936 Hold $24.00→ $26.00+8.3%
Aug 27
13:44 UTC
CSN
Chesnara
◎ Target Royal Bank Of Canada firm only Outperform GBX 360→ GBX 400+11.1%
Aug 27
13:44 UTC
CRM
Salesforce
◎ Target Morgan Stanley Keith Weiss ★★★☆☆ #990 Equal Weight $185.00→ $235.00+27.0%
Aug 27
13:44 UTC
CRM
Salesforce
◎ Target DA Davidson Gil Luria ★★☆☆☆ #2491 Neutral $175.00→ $200.00+14.3%
Aug 27
13:44 UTC
BBWI
Bath & Body Works
◎ Target Morgan Stanley Alex Straton not yet tracked Equal Weight $22.00→ $20.00-9.1%
Aug 27
13:44 UTC
ANF
Abercrombie & Fitch
◎ Target Morgan Stanley Alex Straton not yet tracked Equal Weight $87.00→ $134.00+54.0%
Aug 27
13:44 UTC
ANF
Abercrombie & Fitch
◎ Target Telsey Advisory Group Dana Telsey ★★★☆☆ #991 Outperform $118.00→ $165.00+39.8%
Aug 27
12:45 UTC
SLDB
Solid Biosciences
◎ Target Cantor Fitzgerald Kristen Kluska ★☆☆☆☆ #3064 Overweight $16.00→ $26.00+62.5%
Aug 27
12:45 UTC
RVMD
Revolution Medicines
◎ Target HC Wainwright Robert Burns ★☆☆☆☆ #3091 Buy $195.00→ $280.00+43.6%
Aug 27
12:45 UTC
P
Everpure
◎ Target Needham & Company LLC Mike Cikos ★★★★★ #98 Buy $100.00→ $140.00+40.0%
Aug 27
12:45 UTC
OKTA
Okta
◎ Target Cantor Fitzgerald Jonathan Ruykhaver ★★★★★ #223 Overweight $170.00→ $200.00+17.6%
Aug 27
12:45 UTC
OKTA
Okta
◎ Target BTIG Research Gray Powell ★★★★★ #27 Buy $167.00→ $187.00+12.0%
Aug 27
12:45 UTC
OKTA
Okta
◎ Target Needham & Company LLC Mike Cikos ★★★★★ #98 Buy $140.00→ $200.00+42.9%
Aug 27
12:45 UTC
NVDA
NVIDIA
◎ Target Needham & Company LLC N. Quinn Bolton not yet tracked Buy $270.00→ $300.00+11.1%
Aug 27
12:45 UTC
NTNX
Nutanix
◎ Target Needham & Company LLC Mike Cikos ★★★★★ #98 Buy $60.00→ $85.00+41.7%
Aug 27
12:45 UTC
MDT
Medtronic
◎ Target Needham & Company LLC Mike Matson not yet tracked Buy $101.00→ $114.00+12.9%
Aug 27
12:45 UTC
DY
Dycom Industries
◎ Target Cantor Fitzgerald Manish A. Somaiya not yet tracked Overweight $654.00→ $476.00-27.2%
Aug 27
12:45 UTC
CRM
Salesforce
◎ Target Monness Crespi & Hardt Brian White ★★★★☆ #624 Buy $222.00→ $266.00+19.8%
Aug 27
12:45 UTC
BFST
Business First Bancshares
◎ Target Hovde Group Feddie Strickland ★★★★★ #316 Outperform $36.00→ $37.00+2.8%
Aug 27
12:45 UTC
AMRC
Ameresco
◎ Target Cantor Fitzgerald Manish A. Somaiya not yet tracked Overweight $44.00→ $36.00-18.2%
Aug 27
09:45 UTC
ONT
Oxford Nanopore Technologies
◎ Target JPMorgan Chase & Co. firm only Overweight GBX 190→ GBX 220+15.8%
Aug 27
09:45 UTC
DNLM
Dunelm Group
◎ Target Berenberg Bank firm only Buy GBX 1,332→ GBX 1,200-9.9%
Aug 27
09:45 UTC
ASC
ASOS
◎ Target Shore Capital Group firm only Buy GBX 420→ GBX 520+23.8%
Aug 27
00:44 UTC
ZYME
Zymeworks
◎ Target Citigroup Yigal Nochomovitz ★★☆☆☆ #2804 Buy $37.00→ $38.00+2.7%
Aug 27
00:44 UTC
ZYME
Zymeworks
◎ Target HC Wainwright Robert Burns ★☆☆☆☆ #3091 Buy $51.00→ $55.00+7.8%
Aug 27
00:44 UTC
ZS
Zscaler
◎ Target JPMorgan Chase & Co. Brian Essex ★★★☆☆ #1318 Overweight $205.00→ $215.00+4.9%
Aug 27
00:44 UTC
ZM
Zoom Communications
◎ Target Morgan Stanley Meta Marshall ★★★☆☆ #1570 Equal Weight $105.00→ $107.00+1.9%
Aug 27
00:44 UTC
ZM
Zoom Communications
◎ Target Jefferies Financial Group Samad Samana ★★★★★ #310 Buy $118.00→ $116.00-1.7%
Aug 27
00:44 UTC
WTB
Whitbread
◎ Target Jefferies Financial Group firm only Hold GBX 2,050→ GBX 2,250+9.8%
Aug 27
00:44 UTC
WT
WisdomTree
◎ Target Oppenheimer Chris Kotowski ★★★★☆ #684 Outperform $22.00→ $27.00+22.7%
Aug 27
00:44 UTC
VMRK
Vivmark Residential Common Shares of Beneficial Interest
◎ Target Piper Sandler Alexander Goldfarb ★★★☆☆ #1105 Neutral $75.00→ $76.00+1.3%
Aug 27
00:44 UTC
UGP
Ultrapar Participacoes
◎ Target The Goldman Sachs Group Bruno Amorim ★★☆☆☆ #2499 Neutral $6.50→ $5.80-10.8%
Aug 27
00:44 UTC
TECK.B
Teck Resources
◎ Target Raymond James Financial firm only Outperform C$93.00→ C$105.00+12.9%
Aug 27
00:44 UTC
SYRE
Spyre Therapeutics
◎ Target Deutsche Bank Aktiengesellschaft David Hoang ★★★☆☆ #2207 Buy $135.00→ $127.00-5.9%
Aug 27
00:44 UTC
SYRE
Spyre Therapeutics
◎ Target BTIG Research Julian Harrison ★★☆☆☆ #2874 Buy $132.00→ $121.00-8.3%
Aug 27
00:44 UTC
SYRE
Spyre Therapeutics
◎ Target Wedbush David Nierengarten ★★☆☆☆ #2467 Outperform $130.00→ $123.00-5.4%
Aug 27
00:44 UTC
SNOW
Snowflake
◎ Target Citigroup Tyler Radke ★★★★★ #319 Buy $320.00→ $395.00+23.4%
Aug 27
00:44 UTC
SMTC
Semtech
◎ Target UBS Group Timothy Arcuri ★★☆☆☆ #2448 Buy $225.00→ $230.00+2.2%
Aug 27
00:44 UTC
SMTC
Semtech
◎ Target Morgan Stanley Joseph Moore ★★☆☆☆ #2543 Equal Weight $175.00→ $195.00+11.4%
Aug 27
00:44 UTC
SMPL
Simply Good Foods
◎ Target TD Cowen Robert Moskow ★★★★☆ #388 Hold $13.00→ $11.00-15.4%
🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.
A free account unlocks the full daily feed.
‹ Prev 421 / 876 Next ›

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.